IBRUTinib: BRUTe force against bortezomib-resistant myeloma cells

Cell Cycle. 2015;14(9):1349-50. doi: 10.1080/15384101.2015.1022058.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Bortezomib / toxicity*
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Proteasome Inhibitors / toxicity*
  • Protein-Tyrosine Kinases / metabolism*
  • Pyrazoles / toxicity*
  • Pyrimidines / toxicity*
  • Transcription Factor RelA / metabolism*

Substances

  • Proteasome Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Transcription Factor RelA
  • Bortezomib
  • Protein-Tyrosine Kinases